NOTICE OF INTENT TO SOLE SOURCE Description This notice is issued for informational and market research purposes only and does not constitute a solicitation. The FDA intends to award a sole source Firm-Fixed-Price purchase order for one (1) Whole Genome Sequencing instrument. The Government is considering the Illumina MiSeq i100 System or equal product that meets all salient characteristics identified in the Statement of Work (SOW). Offerors proposing equal products shall demonstrate how the proposed product meets each of the salient characteristics The instrument shall include a minimum one (1) year manufacturer’s warranty covering parts and labor. Response Instructions Interested parties shall submit capability statements demonstrating ability to meet requirements. Offerors proposing an equivalent must clearly demonstrate how requirements are met. Response Deadline March 26, 2026, at 2:30 PM ET Submission Contracting Officer: Iris Johnson Email:
[email protected]